SCHEMBL16432142

SCHEMBL16432142

O=C(CCl)c1ccc(O)cc1Cl

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.69
MAPK1 P28482 1/20 0.69
HIF1A Q16665 1/20 0.69
HSD17B10 Q99714 1/20 0.46
GSK3B P49841 4/20 0.46
ESRRB O95718 1/20 0.44
ESRRG P62508 1/20 0.44
MAPT P10636 3/20 0.44
RAB9A P51151 2/20 0.44
NPC1 O15118 1/20 0.44
CASP3 P42574 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
SENP8 Q96LD8 1/20 0.44
SENP7 Q9BQF6 1/20 0.44
SENP6 Q9GZR1 1/20 0.44
HSP90AB1 P08238 1/20 0.44
ERCC5 P28715 1/20 0.43
FEN1 P39748 1/20 0.43
BACE1 P56817 1/20 0.43
CES2 O00748 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21055979 0.84 ALDH1A1 (0.53) ALDH1A1MAPK1HIF1AHSD17B10GSK3B
SCHEMBL27520109 0.82 HSP90AB1 (0.67) ALDH1A1MAPK1HIF1AHSD17B10ESRRB
SCHEMBL6579360 0.82 PTPN1 (0.48) ALDH1A1MAPK1HIF1AHSD17B10GSK3B
SCHEMBL4828627 0.82 HSP90AB1 (0.66) ALDH1A1MAPK1HIF1AMAPTRAB9A
SCHEMBL30269774 0.82 HSP90AB1 (0.66) ALDH1A1MAPK1HIF1AMAPTRAB9A
SCHEMBL29481555 0.82 ALDH1A1 (1.00) ALDH1A1MAPK1HIF1AGSK3BMAPT
SCHEMBL1691536 0.82 ALDH1A1 (1.00) ALDH1A1MAPK1HIF1AGSK3BMAPT
SCHEMBL11195785 0.79 HTT (0.54) ALDH1A1MAPK1HIF1AHSD17B10ESRRB
SCHEMBL9733934 0.79 KMT2A (0.45) ALDH1A1MAPK1HIF1AHSD17B10MAPT
SCHEMBL1758840 0.79 HSD17B10 (0.54) ALDH1A1HSD17B10ESRRBESRRGMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3027592-B1 NOVEL MICROBIOCIDES SYNGENTA PARTICIPATIONS AG (CH) 2018-12-26 EP disclosed
US-9695123-B2 Microbiocides SYNGENTA PARTICIPATIONS AG (CH) 2017-07-04 US disclosed
US-9695123-B2 Microbiocides SYNGENTA PARTICIPATIONS AG (CH) 2017-07-04 US disclosed
US-9695123-B2 Microbiocides SYNGENTA PARTICIPATIONS AG (CH) 2017-07-04 US disclosed
US-20160168095-A1 NOVEL MICROBIOCIDES SYNGENTA PARTICIPATIONS AG (CH) 2016-06-16 US disclosed
US-20160168095-A1 NOVEL MICROBIOCIDES SYNGENTA PARTICIPATIONS AG (CH) 2016-06-16 US disclosed
US-20160168095-A1 NOVEL MICROBIOCIDES SYNGENTA PARTICIPATIONS AG (CH) 2016-06-16 US disclosed
EP-3027592-A1 NOVEL MICROBIOCIDES Syngenta Participations AG (CH) 2016-06-08 EP disclosed
WO-2015014733-A1 NOVEL MICROBIOCIDES SYNGENTA PARTICIPATIONS AG (CH) 2015-02-05 WO disclosed
WO-2015014733-A1 NOVEL MICROBIOCIDES SYNGENTA PARTICIPATIONS AG (CH) 2015-02-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160168095-A1 NOVEL MICROBIOCIDES MSR1, C1R, C5AR1 ALDH1A1 3060/4885MAPK1 1823/4885HIF1A 1649/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.